Altamira Therapeutics Ltd - Warrants (29/03/2028) Accounts Payable

Altamira Therapeutics Ltd - Warrants (29/03/2028) (CYTOW) currently reports a accounts payable of $520K as of December 2024. That compares with $410K in the prior-year period — up 27.0% year over year. Use the charts on this page to explore Altamira Therapeutics Ltd - Warrants (29/03/2028)'s accounts payable history and peer comparisons.

Altamira Therapeutics Ltd - Warrants (29/03/2028)'s accounts payable increased from $410K to $520K — a 27.0% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Altamira Therapeutics Ltd - Warrants (29/03/2028) reported $520K in accounts payable as of December 2024. That compares with $410K in the prior-year period — up 27.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $520K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Altamira Therapeutics Ltd - Warrants (29/03/2028), and consider following CYTOW for alerts when major investors trade the stock.

Altamira Therapeutics Ltd - Warrants (29/03/2028) is classified in the Healthcare sector. On accounts payable, it currently shows $520K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYTOW with unrelated industries.